These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 579712)

  • 1. The kinetics of imipramine-N-oxide in man.
    Nagy A; Hansen T
    Acta Pharmacol Toxicol (Copenh); 1978 Jan; 42(1):58-67. PubMed ID: 579712
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels of imipramine and desipramine in man after different routes of administration.
    Nagy A; Johansson R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):145-60. PubMed ID: 1102994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting imipramine dose in children with depression.
    Sallee F; Stiller R; Perel J; Rancurello M
    Clin Pharmacol Ther; 1986 Jul; 40(1):8-13. PubMed ID: 3720179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Variations in the blood levels of imipramine and desmethylimipramine, depending upon the route of administration, intramuscular or oral, of Tofranil].
    Rigal J; Albin H; França X; Vinçon G; Démotes-Mainard F
    Ann Med Psychol (Paris); 1988; 146(8):764-72. PubMed ID: 3242402
    [No Abstract]   [Full Text] [Related]  

  • 5. The kinetics of imipramine-N-oxide in rats.
    Nagy A
    Acta Pharmacol Toxicol (Copenh); 1978 Jan; 42(1):68-72. PubMed ID: 579713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the kinetics of imipramine and related antidepressants.
    Nagy A
    Acta Psychiatr Scand Suppl; 1980; 280():147-56. PubMed ID: 6931475
    [No Abstract]   [Full Text] [Related]  

  • 7. First-pass metabolism of imipramine in man.
    Gram LF; Christiansen J
    Clin Pharmacol Ther; 1975 May; 17(5):555-63. PubMed ID: 1126113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood and brain concentrations of imipramine, clomipramine and their monomethylated metabolites after oral and intramuscular administration in rats.
    Nagy A
    J Pharm Pharmacol; 1977 Feb; 29(2):104-7. PubMed ID: 15053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipramine and desipramine plasma levels: relationship to dosage schedule and sampling time.
    Ziegler VE; Biggs JT; Rosen SH; Meyer DA; Preskorn SH
    J Clin Psychiatry; 1978 Aug; 39(8):660-3. PubMed ID: 681303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative clinical evaluation of lofepramine and imipramine. Pharmacological aspects.
    Siwers B; Borg S; d'Elia G; Lundin G; Forshell GP; Raotma H; Román G
    Acta Psychiatr Scand; 1977 Jan; 55(1):21-31. PubMed ID: 320828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-pass metabolism of imipramine and desipramine: impact of the sparteine oxidation phenotype.
    Brøsen K; Gram LF
    Clin Pharmacol Ther; 1988 Apr; 43(4):400-6. PubMed ID: 3356084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipramine metabolites in blood of patients during therapy and after overdose.
    Gram LF; Bjerre M; Kragh-Sørensen P; Kvinesdal B; Molin J; Pedersen OL; Reisby N
    Clin Pharmacol Ther; 1983 Mar; 33(3):335-42. PubMed ID: 6825388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The demethylation of imipramine and clomipramine as apparent from their plasma kinetics.
    Nagy A; Johansson R
    Psychopharmacology (Berl); 1977 Oct; 54(2):125-31. PubMed ID: 412206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active metabolites of imipramine and desipramine in man.
    Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of hypnotics on imipramine treatment.
    Ballinger BR; Presly A; Reid AH; Stevenson IH
    Psychopharmacologia; 1974; 39(3):267-74. PubMed ID: 4427993
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiarrhythmic plasma-concentration range of imipramine against ventricular premature depolarizations.
    Giardina EG; Louie M; Bigger JT; Brem R; Alchevsky D
    Clin Pharmacol Ther; 1983 Sep; 34(3):284-9. PubMed ID: 6883904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state levels of imipramine and its metabolites: significance of dose-dependent kinetics.
    Brøsen K; Gram LF; Klysner R; Bech P
    Eur J Clin Pharmacol; 1986; 30(1):43-9. PubMed ID: 3709631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on plasma level/effect relationships in imipramine therapy.
    Perel JM; Stiller RL; Glassman AH
    Commun Psychopharmacol; 1978; 2(5):429-39. PubMed ID: 738021
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical pharmacology of imipramine. Implications for therapeutics.
    Glassman AH; Perel JM
    Arch Gen Psychiatry; 1973 May; 28(5):649-53. PubMed ID: 4573419
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma levels of imipramine in depression. Environmental and genetic factors.
    Perel JM; Mendlewicz J; Shostak M; Kantor SJ; Glassman AH
    Neuropsychobiology; 1976; 2(4):193-202. PubMed ID: 1012454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.